Showing results (81-90 of 137) with videos related to

Sort By:
Pageof 14
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 2, 2024
Lenvatinib radiofrequency ablation sequential therapy offers survival benefits for patients with unresectable hepatocellular carcinoma at intermediate stage and the liver reserve of Child-Pugh A category: A multicenter studyYing Zhang, Kazushi Numata, Kento Imajo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 26, 2021
A genome-wide association study identifying SVEP1 variant as a predictor of response to tolvaptan for cirrhotic ascitesHideto Kawaratani, Hiromi Sawai, Masaya Onishi, et al.
Hepatology Communications|October 7, 2025
Denosumab versus zoledronic acid for osteoporosis treatment in patients with primary biliary cholangitis (the DELTA Study): A multicenter, non-inferiority randomized trialYoshitaka Arase, Tomomi Okubo, Taeang Arai, et al.
Alimentary Pharmacology & Therapeutics|May 6, 2026
Rifaximin Improves Cognitive Performance and Reduces Cirrhosis-Related Adverse Events in Covert Hepatic Encephalopathy: A Randomized Controlled TrialHiroki Inada, Toshinori Toyota, Haruki Uojima, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 29, 2018
Efficacy and safety of ombitasvir/paritaprevir/ritonavir and ribavirin for chronic hepatitis patients infected with genotype 2a in JapanMasanori Atsukawa, Akihito Tsubota, Hidenori Toyoda, et al.
Hepatology Communications|July 19, 2021
Characteristics and Prognosis of De Novo Hepatocellular Carcinoma After Sustained Virologic ResponseHidenori Toyoda, Atsushi Hiraoka, Haruki Uojima, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 30, 2024
Kinetics of the hepatitis B core-related antigen and treatment responses in chronic hepatitis B patients treated with tenofovir alafenamideNorio Itokawa, Masanori Atsukawa, Akihito Tsubota, et al.
Gastro Hep Advances|August 12, 2024
The Impact of Cirrhosis and History of Hepatocellular Carcinoma on All-Cause Mortality After Eradication of Hepatitis C Virus in Patients With Chronic Hepatitis CHidenori Toyoda, Masanori Atsukawa, Haruki Uojima, et al.
Hepatology International|July 4, 2024
Clinical significance of circulating biomarkers of immune-checkpoint molecules with atezolizumab plus bevacizumab therapy in unresectable hepatocellular carcinomaMakoto Chuma, Haruki Uojima, Hidenori Toyoda, et al.
Journal of Gastroenterology and Hepatology|January 31, 2024
Comparison of six hepatocellular carcinoma prediction models in Japanese patients after sustained virologic response undergoing rigorous surveillance for hepatocellular carcinomaHidenori Toyoda, Toshifumi Tada, Haruki Uojima, et al.
Pageof 14